Cosmos Health Stock Performance
| COSM Stock | USD 0.51 0.01 2.60% |
The firm shows a Beta (market volatility) of 1.37, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cosmos Health will likely underperform. At this point, Cosmos Health has a negative expected return of -0.0367%. Please make sure to confirm Cosmos Health's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Cosmos Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Cosmos Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Cosmos Health is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Last Split Factor 1:10 | Dividend Date 2017-11-21 | Last Split Date 2017-11-21 |
1 | Acquisition by Grigorios Siokas of 257334 shares of Cosmos Health at 0.5829 subject to Rule 16b-3 | 12/20/2024 |
2 | Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at 200,000 | 12/23/2024 |
3 | Acquisition by Grigorios Siokas of 4474 shares of Cosmos Health at 23.92 subject to Rule 16b-3 | 01/06/2025 |
4 | Acquisition by Grigorios Siokas of 87247 shares of Cosmos Health at 0.6877 subject to Rule 16b-3 | 01/14/2025 |
5 | Acquisition by Grigorios Siokas of 47904 shares of Cosmos Health at 0.835 subject to Rule 16b-3 | 01/16/2025 |
6 | Acquisition by Grigorios Siokas of 38900 shares of Cosmos Health at 0.7712 subject to Rule 16b-3 | 01/22/2025 |
7 | Fast-paced Momentum Stock Cosmos Health Inc. Is Still Trading at a Bargain | 01/23/2025 |
8 | Acquisition by Grigorios Siokas of 51414 shares of Cosmos Health at 0.6613 subject to Rule 16b-3 | 01/30/2025 |
9 | Cosmos Health Pockets 10-Year Manufacturing Deal With Provident Pharmaceuticals | 02/07/2025 |
10 | Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy Operations | 02/10/2025 |
11 | Cosmos Health Inc. Expands IP Portfolio with AI-Driven Drug Repurposing Patents | 02/12/2025 |
12 | Insider Trading | 02/14/2025 |
13 | Bullish Cosmos Health Insiders Loaded Up On US539.0k Of Stock | 02/20/2025 |
14 | Acquisition by Grigorios Siokas of 354296 shares of Cosmos Health at 0.5645 subject to Rule 16b-3 | 02/24/2025 |
15 | Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates | 02/26/2025 |
16 | Acquisition by Grigorios Siokas of 132572 shares of Cosmos Health at 0.4903 subject to Rule 16b-3 | 03/03/2025 |
17 | Acquisition by Grigorios Siokas of 85714 shares of Cosmos Health at 0.525 subject to Rule 16b-3 | 03/04/2025 |
18 | Disposition of tradable shares by Aslidis Anastasios of Cosmos Health subject to Rule 16b-3 | 03/06/2025 |
19 | Acquisition by Grigorios Siokas of 4474 shares of Cosmos Health at 24.64 subject to Rule 16b-3 | 03/07/2025 |
| Begin Period Cash Flow | 20.7 M |
Cosmos |
Cosmos Health Relative Risk vs. Return Landscape
If you would invest 58.00 in Cosmos Health on December 20, 2024 and sell it today you would lose (7.00) from holding Cosmos Health or give up 12.07% of portfolio value over 90 days. Cosmos Health is currently does not generate positive expected returns and assumes 5.9709% risk (volatility on return distribution) over the 90 days horizon. In different words, 53% of stocks are less volatile than Cosmos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cosmos Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cosmos Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cosmos Health, and traders can use it to determine the average amount a Cosmos Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0061
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | COSM |
Estimated Market Risk
| 5.97 actual daily | 53 53% of assets are less volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cosmos Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cosmos Health by adding Cosmos Health to a well-diversified portfolio.
Cosmos Health Fundamentals Growth
Cosmos Stock prices reflect investors' perceptions of the future prospects and financial health of Cosmos Health, and Cosmos Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cosmos Stock performance.
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.36) % | ||||
| Operating Margin | (0.18) % | ||||
| Current Valuation | 18.87 M | ||||
| Shares Outstanding | 23.26 M | ||||
| Price To Earning | 2.41 X | ||||
| Price To Book | 0.32 X | ||||
| Price To Sales | 0.21 X | ||||
| Revenue | 53.38 M | ||||
| Gross Profit | 4.54 M | ||||
| EBITDA | (17.06 M) | ||||
| Net Income | (18.54 M) | ||||
| Cash And Equivalents | 322.37 K | ||||
| Total Debt | 12.42 M | ||||
| Debt To Equity | 4.79 % | ||||
| Current Ratio | 1.05 X | ||||
| Book Value Per Share | 1.50 X | ||||
| Cash Flow From Operations | (15.64 M) | ||||
| Earnings Per Share | (2.54) X | ||||
| Market Capitalization | 11.57 M | ||||
| Total Asset | 66.01 M | ||||
| Retained Earnings | (91.64 M) | ||||
| Working Capital | 12.29 M | ||||
| Current Asset | 6.37 M | ||||
| Current Liabilities | 1.61 M | ||||
About Cosmos Health Performance
By examining Cosmos Health's fundamental ratios, stakeholders can obtain critical insights into Cosmos Health's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Cosmos Health is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 41.00 | 48.22 | |
| Return On Tangible Assets | (0.29) | (0.30) | |
| Return On Capital Employed | (0.60) | (0.57) | |
| Return On Assets | (0.25) | (0.27) | |
| Return On Equity | (0.59) | (0.56) |
Things to note about Cosmos Health performance evaluation
Checking the ongoing alerts about Cosmos Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cosmos Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cosmos Health generated a negative expected return over the last 90 days | |
| Cosmos Health has high historical volatility and very poor performance | |
| Cosmos Health has some characteristics of a very speculative penny stock | |
| Cosmos Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 53.38 M. Net Loss for the year was (18.54 M) with profit before overhead, payroll, taxes, and interest of 4.54 M. | |
| Cosmos Health currently holds about 322.37 K in cash with (15.64 M) of positive cash flow from operations. | |
| Roughly 30.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Grigorios Siokas of 38900 shares of Cosmos Health at 0.7712 subject to Rule 16b-3 |
- Analyzing Cosmos Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cosmos Health's stock is overvalued or undervalued compared to its peers.
- Examining Cosmos Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cosmos Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cosmos Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cosmos Health's stock. These opinions can provide insight into Cosmos Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.54) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.